Antacid Market: Rise in Prevalence of Gastroesophageal Reflux Disease (GERD)
The antacid market is expected to reach US$ 11,666.83 million in 2027 from US$ 8,547.97 million in 2019. The market is estimated to grow with a CAGR of 4.0% from 2020-2027.
The class of drugs that neutralize the acid in the stomach are known as antacids. It is used to treat conditions like heartburn, indigestion, acidity and an upset stomach. These drugs are available over the counter and are usually consumed by mouth. They are available in tablets, capsules, liquid and powder form. There are different types of antacid available like aluminium hydroxide, magnesium carbonate, magnesium trisilicate, magnesium hydroxide, calcium carbonate, and sodium bicarbonate. The global antacid market growth is mainly attributed to factors such as increasing prevalence of GERD, and rising prevalence of obesity. However, low awareness associated with gastrointestinal disorders in low-income economies is restricting the Antacid market growth.
Request for sample Report at: https://www.theinsightpartners.com/sample/TIPRE00016359/
Key Findings from The Antacid Market
- The antacid market, by dosage form, is segmented into tablet, liquid, and others. The tablet segment held the largest share of the market in 2019, whereas the liquid segment is anticipated to register the highest CAGR in the market during the forecast period. Factors such as availability of different types of antacid tablets, easy storage and accurate dosage are contributing to the growth of the segment.
- The antacid market, by drug class, is segmented into proton pump inhibitors, H2 antagonist, acid neutralizers. The proton pump inhibitors segment held the largest share of the market in 2019, and the same segment is anticipated to register the highest CAGR in the market during the forecast period.
- Based on distribution channel, the antacid market is segmented into hospital pharmacy, retail pharmacy, and online pharmacy. The retail pharmacy segment held the largest share of the market in 2019. Also, the same segment is estimated to register the highest CAGR in the market during the forecast period.
- Sanofi, GlaxoSmithKline plc, Bayer AG, Takeda Pharmaceutical Company Limited, Sun Pharmaceuticals Ltd, Boehringer Ingelheim International Gmbh, Dr. Reddy’s Laboratories Ltd., Pfizer, Inc, Reckitt Benckiser Group Plc., and Procter And Gamble are among the leading companies operating in the antacid market.
Rise in Prevalence of Gastroesophageal Reflux Disease (GERD)
Gastroesophageal reflux disease (GERD), a digestive disorder that affects the ring of muscle between esophagus and stomach, is a chronic and highly prevalent disorder. As per the report ‘Update on the epidemiology of gastro-esophageal reflux disease: a systematic review’ published in 2014, the prevalence of GERD is 18.1–27.8% in North America, 2.5–7.8% in East Asia, 8.8–25.9% in Europe, 8.7–33.1% in the Middle East, 11.6% in Australia, and 23.0% in South America.
Furthermore, the National GI Survey was conducted and completed in 2015 and was the first major attempt to measure the prevalence of GERD in the US since 2005. As per the survey, 18% of the 71,000 people reported episodes of GERD twice a week and 31% reported GERD episodes once a week. The survey also reported that 35% of these patients used medications to control the condition and 55% of these used proton-pump inhibitors as their medication therapy. Additionally, the survey reported that the condition is more prevalent in women than in men. Thus, the factors mentioned above are driving the adoption of antacids during the forecast period.
Global Antacid Market – by Dosage Form
Global Antacid Market – by Drug Class
- Proton pump inhibitors
- H2 Antagonist
- Acid neutralizers
Global Antacid Market – by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Place an Order Now: https://www.theinsightpartners.com/buy/TIPRE00016359/
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
We are committed to provide highest quality research and consulting services to our customers. We help our clients understand the key market trends, identify opportunities, and make informed decisions with our market research offerings at an affordable cost.
Contact Person: Sameer Joshi